Skip to main content

Advertisement

Log in

Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies

  • Case Reports
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

The past decade has seen a dramatic increase in the number of new head and neck tumor entities, most of which are genetically defined. DEK::AFF2 carcinoma is one of the most recently defined neoplasms; it shows a non-keratinizing squamous morphology and occurs in the sinonasal region. We present an unusual neoplasm that was found to harbor a novel fusion involving AFF2. The case was encountered in our clinical practice. Immunohistochemistry was performed along with targeted next generation sequencing (NGS). The case presented as a metastasis to a cervical lymph node from an unknown primary, in a 49-year-old man. The tumor consisted of sheets of primitive round cells which were strongly positive for synaptophysin and chromogranin but negative for cytokeratins, S-100 protein, WT-1, desmin, and many other markers. NGS uncovered CHD4::AFF2. We found a CHD4::AFF2 fusion in a high-grade neuroendocrine tumor. Although it is just a single case, the presence of a novel fusion in a neoplasm that is otherwise not classifiable suggests that it could be a distinct entity within a possible family of AFF2-rearranged tumors. Molecular analysis should be considered for any unclassified round cell tumor in the head and neck, as additional cases will be needed to further elucidate this area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Availability of data and material is possible upon reasonable request, deidentified for maintenance of anonymity and compliance with IRB approval.

Code availability

Not applicable.

References

  1. Rooper LM, Thompson LDR, Gagan J, Oliai BR, Weinreb I, Bishop JA. Salivary intraductal carcinoma arising within intraparotid lymph node: a report of 4 cases with identification of a novel STRN-ALK fusion. Head Neck Pathol. 2021;15(1):179–85. https://doi.org/10.1007/s12105-020-01198-0.

    Article  PubMed  Google Scholar 

  2. Rooper LM, Agaimy A, Dickson BC, et al. DEK-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity. Am J Surg Pathol. 2021;45:1693.

    Google Scholar 

  3. Bishop JA, Gagan J, Paterson C, McLellan D, Sandison A. Nonkeratinizing squamous cell carcinoma of the sinonasal tract with DEK-AFF2: further solidifying an emerging entity. Am J Surg Pathol. 2021;45(5):718–20. https://doi.org/10.1097/PAS.0000000000001596.

    Article  PubMed  Google Scholar 

  4. Todorovic E, Truong T, Eskander A, et al. Middle ear and temporal bone nonkeratinizing squamous cell carcinomas with DEK-AFF2 fusion: an emerging entity. Am J Surg Pathol. 2020;44(9):1244–50. https://doi.org/10.1097/PAS.0000000000001498.

    Article  PubMed  Google Scholar 

  5. Kuo YJ, Lewis JS, Zhai C, et al. DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology. Mod Pathol. 2021;34(10):1820–30. https://doi.org/10.1038/s41379-021-00846-2.

    Article  CAS  PubMed  Google Scholar 

  6. Agaimy A, Bishop JA. SWI/SNF-deficient head and neck neoplasms: an overview. Semin Diagn Pathol. 2021;38(3):175–82. https://doi.org/10.1053/j.semdp.2021.02.002.

    Article  PubMed  Google Scholar 

  7. Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608. https://doi.org/10.1097/PAS.0b013e3181d9efcc.

    Article  PubMed  Google Scholar 

  8. Napolitano M, Venturelli M, Molinaro E, Toss A. NUT midline carcinoma of the head and neck: current perspectives. OncoTargets Ther. 2019;12:3235–44. https://doi.org/10.2147/OTT.S173056.

    Article  CAS  Google Scholar 

  9. McCuiston A, Bishop JA. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors. Head Neck Pathol. 2018;12(1):89–94. https://doi.org/10.1007/s12105-017-0830-1.

    Article  PubMed  Google Scholar 

  10. Guilmette J, Sadow PM. High-grade sinonasal carcinoma: classification through molecular profiling. Arch Pathol Lab Med. 2019;143(11):1416–9. https://doi.org/10.5858/arpa.2018-0224-RS.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Wang X, Bledsoe KL, Graham RP, et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet. 2014;46(7):666–8. https://doi.org/10.1038/ng.2989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Huang SC, Ghossein RA, Bishop JA, et al. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol. 2016;40(1):51–9. https://doi.org/10.1097/PAS.0000000000000492.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol. 2017;30(5):650–9. https://doi.org/10.1038/modpathol.2016.239.

    Article  CAS  PubMed  Google Scholar 

  14. Chau NG, Hurwitz S, Mitchell CM, et al. Intensive treatment and survival outcomes in NUT midline carcinoma (NMC) of the head and neck (HN). Cancer. 2016;122(23):3632–40. https://doi.org/10.1002/cncr.30242.

    Article  PubMed  Google Scholar 

  15. French C. NUT midline carcinoma. Nat Rev Cancer. 2014;14(3):149–50. https://doi.org/10.1038/nrc3659.

    Article  CAS  PubMed  Google Scholar 

  16. Mittal P, Roberts CWM. The SWI/SNF complex in cancer—biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17(7):435–48. https://doi.org/10.1038/s41571-020-0357-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15(12):731–47. https://doi.org/10.1038/s41571-018-0113-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Centore RC, Sandoval GJ, Soares LMM, Kadoch C, Chan HM. Mammalian SWI/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies. Trends Genet. 2020;36(12):936–50. https://doi.org/10.1016/j.tig.2020.07.011.

    Article  CAS  PubMed  Google Scholar 

  19. Bishop JA. Recently described neoplasms of the sinonasal tract. Semin Diagn Pathol. 2016;33(2):62–70. https://doi.org/10.1053/j.semdp.2015.12.001.

    Article  PubMed  Google Scholar 

  20. Melko M, Douguet D, Bensaid M, et al. Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability. Hum Mol Genet. 2011;20(10):1873–85. https://doi.org/10.1093/hmg/ddr069.

    Article  CAS  PubMed  Google Scholar 

  21. Meyer C, Burmeister T, Gröger D, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273–84. https://doi.org/10.1038/leu.2017.213.

    Article  CAS  PubMed  Google Scholar 

  22. Sandén C, Gullberg U. The DEK oncoprotein and its emerging roles in gene regulation. Leukemia. 2015;29(8):1632–6. https://doi.org/10.1038/leu.2015.72.

    Article  CAS  PubMed  Google Scholar 

  23. Böhm F, Kappes F, Scholten I, et al. The SAF-box domain of chromatin protein DEK. Nucleic Acids Res. 2005;33(3):1101–10. https://doi.org/10.1093/nar/gki258.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ng MHJ, Ng RK, Kong CT, Jin DY, Chan LC. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins. Exp Hematol. 2010;38(6):481–8. https://doi.org/10.1016/j.exphem.2010.03.014.

    Article  CAS  PubMed  Google Scholar 

  25. Harman JR, Thorne R, Jamilly M, et al. A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes. Genome Res. 2021. https://doi.org/10.1101/gr.268490.120.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mansfield RE, Musselman CA, Kwan AH, et al. Plant homeodomain (PHD) fingers of CHD4 are histone H3-binding modules with preference for unmodified H3K4 and methylated H3K9. J Biol Chem. 2011;286(13):11779–91. https://doi.org/10.1074/jbc.M110.208207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Watson AA, Mahajan P, Mertens HDT, et al. The PHD and chromo domains regulate the ATPase activity of the human chromatin remodeler CHD4. J Mol Biol. 2012;422(1):3–17. https://doi.org/10.1016/j.jmb.2012.04.031.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was funded by the Jane B. and Edwin P. Jenevein Endowment for Pathology at UT Southwestern Medical Center. No external funding was obtained for this study.

Author information

Authors and Affiliations

Authors

Contributions

All authors confirm they have meaningfully contributed to the research and read and approved the final manuscript.

Corresponding author

Correspondence to Justin A. Bishop.

Ethics declarations

Conflicts of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in this retrospective data analysis involving human participants were in accordance with the ethical standards of the institutional review board (IRB 112017–073), which did not require informed consent.

Consent to participate

The IRB-approved study was classified as exempt, which does not require informed consent.

Consent for publication

Consent for publication was obtained from all individual participants for whom identifying information is uniquely included in this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miller, D.L., Palsgrove, D.N., Rijal, A. et al. Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies. Head and Neck Pathol 16, 928–933 (2022). https://doi.org/10.1007/s12105-022-01432-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-022-01432-x

Keywords

Navigation